Figure 4.1
Prevalence of common cardiovascular diseases in patients with or without CKD, 2015
Prevalence of common cardiovascular diseases in patients with or without CKD, 2015
Data Source: Special analyses, Medicare 5% sample. Abbreviations: AF, atrial fibrillation; AMI, acute myocardial infarction; CAD, coronary artery disease; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; HF, heart failure; PAD, peripheral arterial disease; SCA/VA, sudden cardiac arrest and ventricular arrhythmias; VHD, valvular heart disease; VTE/PE, venous thromboembolism and pulmonary embolism.

Cardiovascular comorbidities
Cardiovascular procedures

ICD-9-CM and ICD-10-CM codes for Chronic Kidney Disease (CKD) stages

Figure 4.2
Probability of survival of patients with a prevalent cardiovascular disease, by CKD status, adjusted for age and sex, 2014-2015
(a) Coronary artery disease (CAD)
Coronary artery disease (CAD)
(b) Acute myocardial infarction (AMI)
Acute myocardial infarction (AMI)
(c) Heart failure (HF)
Heart failure (HF)
(d) Valvular heart disease (VHD)
Valvular heart disease (VHD)
(e) Cerebrovascular accident/transient ischemic attack (CVA/TIA)
Cerebrovascular accident/transient ischemic attack (CVA/TIA)
(f) Peripheral arterial disease (PAD)
Peripheral arterial disease (PAD)
(g) Atrial fibrillation (AF)
Atrial fibrillation (AF)
(h) Sudden cardiac arrest and ventricular arrhythmias (SCA/VA)
Sudden cardiac arrest and ventricular arrhythmias (SCA/VA)
(i) Venous thromboembolism and pulmonary embolism (VTE/PE)
Venous thromboembolism and pulmonary embolism (VTE/PE)
Data Source: Special analyses, Medicare 5% sample. Patients aged 66 and older, alive, without end-stage renal disease, and residing in the United States on 12/31/2013, with fee-for-service coverage for the entire calendar year. Abbreviations: CKD, chronic kidney disease.

Two-year survival of patients with a prevalent cardiovascular disease, by CKD status, adjusted for age and sex, 2014-2015

Figure 4.3
Probability of survival of patients with a cardiovascular procedure, by CKD status, adjusted for age and sex, 2013-2015
(a) Percutaneous coronary interventions (PCI)
Percutaneous coronary interventions (PCI)
(b) Coronary artery bypass grafting (CABG)
Coronary artery bypass grafting (CABG)
(c) Implantable cardioverter defibrillators/cardiac resynchronization therapy with defibrillator devices (ICD/CRT-D)
Implantable cardioverter defibrillators/cardiac resynchronization therapy with defibrillator devices (ICD/CRT-D)
(d) Carotid artery stenting and carotid endarterectomy (CAS/CEA)
Carotid artery stenting and carotid endarterectomy (CAS/CEA)
Data Source: Special analyses, Medicare 5% sample. Patients aged 66 and older, alive, without end-stage renal disease, and residing in the United States on the index date, which was the date of the first procedure claim, with fee-for-service coverage for the entire year prior to this date. Abbreviations: CKD, chronic kidney disease.

Two-year survival of patients with a cardiovascular procedure, by CKD status, adjusted for age and sex, 2013-2015

Cardiovascular comorbidities
Cardiovascular procedures

Figure 4.4
Heart failure in patients with or without CKD, 2015
Heart failure in patients with or without CKD, 2015
Data Source: Special analyses, Medicare 5% sample. Patients aged 66 and older, alive, without end-stage renal disease, and residing in the U.S. on 12/31/2015 with fee-for-service coverage for the entire calendar year. Abbreviation: CKD, chronic kidney disease.

Figure 4.5
Adjusted survival of patients by CKD and heart failure status, 2014-2015
Adjusted survival of patients by CKD and heart failure status, 2014-2015
Data Source: Special analyses, Medicare 5% sample. Patients aged 66 and older, alive, without end-stage renal disease, and residing in the U.S. on 12/31/2013 with fee-for-service coverage for the entire calendar year. Survival is adjusted for age, sex, race, diabetic status, and hypertension status. Abbreviations: CKD, chronic kidney disease.

Prevalence of atrial fibrillation by stage of CKD, age, race, sex, and diabetic, hypertension, and heart failure status, 2015